Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
index medicus (55) 55
female (50) 50
middle aged (44) 44
adult (40) 40
aged (34) 34
male (33) 33
oncology (29) 29
young adult (19) 19
abridged index medicus (17) 17
aged, 80 and over (17) 17
article (17) 17
prognosis (17) 17
cancer (14) 14
neoplasm staging (13) 13
pathology (13) 13
survival (13) 13
adolescent (12) 12
melanoma (12) 12
retrospective studies (12) 12
disease-free survival (11) 11
metastasis (11) 11
skin neoplasms - pathology (11) 11
follow-up studies (10) 10
melanoma - pathology (10) 10
diagnosis (9) 9
medicine, research & experimental (9) 9
research (9) 9
risk factors (9) 9
breast cancer (8) 8
child (8) 8
melanoma - genetics (8) 8
reproducibility of results (8) 8
sensitivity and specificity (8) 8
treatment outcome (8) 8
carcinoma (7) 7
care and treatment (7) 7
chemotherapy (7) 7
health aspects (7) 7
immunotherapy (7) 7
medicine & public health (7) 7
melanoma - mortality (7) 7
mortality (7) 7
mutation (7) 7
radiology, nuclear medicine & medical imaging (7) 7
survival rate (7) 7
analysis (6) 6
expression (6) 6
immunohistochemistry (6) 6
patient outcomes (6) 6
proto-oncogene proteins b-raf - genetics (6) 6
risk (6) 6
skin neoplasms - genetics (6) 6
skin neoplasms - mortality (6) 6
therapy (6) 6
transplantation (6) 6
animals (5) 5
biopsy (5) 5
breast (5) 5
breast neoplasms - pathology (5) 5
genetic aspects (5) 5
immunology (5) 5
malignant-melanoma (5) 5
medicine, general & internal (5) 5
melanoma - drug therapy (5) 5
melanoma - secondary (5) 5
nuclear medicine (5) 5
patients (5) 5
surgery (5) 5
tumors (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
breast neoplasms - diagnosis (4) 4
breast-cancer (4) 4
cell line, tumor (4) 4
clinical trials (4) 4
dermatology (4) 4
gene expression (4) 4
imaging / radiology (4) 4
logistic models (4) 4
lymphatic metastasis (4) 4
management (4) 4
medical research (4) 4
metastases (4) 4
multivariate analysis (4) 4
neoadjuvant therapy (4) 4
neoplasm invasiveness (4) 4
open-label (4) 4
orthopedics (4) 4
phosphorylation (4) 4
predictive value of tests (4) 4
risk assessment (4) 4
skin neoplasms - drug therapy (4) 4
stem cell transplantation (4) 4
tomography, x-ray computed (4) 4
trial (4) 4
women (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
apoptosis (3) 3
bibliography (3) 3
biomarkers, tumor - metabolism (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (7) 7
Gerstein Science - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Scarborough - Stacks (3) 3
Royal Ontario Museum - Missing (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text NRAS mutation status is an independent prognostic factor in metastatic melanoma
by Jakob, John A and Bassett, Roland L and Ng, Chaan S and Curry, Jonathan L and Joseph, Richard W and Alvarado, Gladys C and Rohlfs, Michelle L and Richard, Jessie and Gershenwald, Jeffrey E and Kim, Kevin B and Lazar, Alexander J and Hwu, Patrick and Davies, Michael A
Cancer, ISSN 0008-543X, 08/2012, Volume 118, Issue 16, pp. 4014 - 4023
BACKGROUND: There is a need for improved prognostic markers in melanoma. In this study, the authors tested the prognostic significance and clinicopathologic... 
NRAS | malignant melanoma | metastasis | oncogenes | Homo sapiens | BRAF | oncogene | human | BRAF oncogene | NRAS oncogenes | ONCOLOGY | BRAF MUTATIONS | CUTANEOUS MELANOMA | AMERICAN JOINT COMMITTEE | FEATURES | Skin Neoplasms - pathology | Prognosis | Gene Frequency | Humans | Middle Aged | Melanoma - pathology | Melanoma - secondary | Neoplasm Metastasis | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Skin Neoplasms - mortality | Skin Neoplasms - genetics | Female | Mutation | Genes, ras | Melanoma - mortality | Care and treatment | Research | Mutation (Biology) | Melanoma | B-Raf protein | Metastasis | Malignant Melanoma | N-ras Oncogenes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma
by Bucheit, Amanda D and Syklawer, Erica and Jakob, John A and Bassett, Roland L and Curry, Jonathan L and Gershenwald, Jeffrey E and Kim, Kevin B and Hwu, Patrick and Lazar, Alexander J and Davies, Michael A
Cancer, ISSN 0008-543X, 11/2013, Volume 119, Issue 21, pp. 3821 - 3829
Certain recurrent mutations in BRAF and NRAS are present in many patients with melanoma. Comparison of patients with advanced melanoma with the most common... 
melanoma | NRAS | BRAF | prognostic factor | stage IV | clinical features | MEK INHIBITOR TRAMETINIB | DABRAFENIB | MULTICENTER | DOSE-ESCALATION TRIAL | IMPROVED SURVIVAL | OPEN-LABEL | CANCER | V600E | ONCOLOGY | SELUMETINIB | VEMURAFENIB | Skin Neoplasms - pathology | Melanoma - diagnosis | Prognosis | Humans | Middle Aged | Male | Melanoma - pathology | Mutation - physiology | Neoplasm Metastasis | DNA Mutational Analysis | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Skin Neoplasms - diagnosis | Skin Neoplasms - genetics | Adult | Female | Retrospective Studies | Cohort Studies | Genes, ras - genetics | Genetic aspects | Research | Metastasis | Gene mutations | Patient outcomes | Melanoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Loss of PTEN promotes resistance to T cell–mediated immunotherapy
by Peng, Weiyi and Chen, Jie Qing and Liu, Chengwen and Malu, Shruti and Creasy, Caitlin and Tetzlaff, Michael T and Xu, Chunyu and McKenzie, Jodi A and Zhang, Chunlei and Liang, Xiaoxuan and Williams, Leila J and Deng, Wanleng and Chen, Guo and Mbofung, Rina and Lazar, Alexander J and Torres-Cabala, Carlos A and Cooper, Zachary A and Chen, Pei-Ling and Tieu, Trang N and Spranger, Stefani and Yu, Xiaoxing and Bernatchez, Chantale and Forget, Marie-Andree and Haymaker, Cara and Amaria, Rodabe and McQuade, Jennifer L and Glitza, Isabella C and Cascone, Tina and Li, Haiyan S and Kwong, Lawrence N and Heffernan, Timothy P and Hu, Jianhua and Bassett, Roland L and Bosenberg, Marcus W and Woodm An, Scott E and Overwijk, Willem W and Lizee, Gregory and Roszik, Jason and Gajewski, Thomas F and Wargo, Jennifer A and Gershenwald, Jeffrey E and Radvanyi, Laszlo and Davies, Michael A and Hwu, Patrick
Cancer Discovery, ISSN 2159-8274, 02/2016, Volume 6, Issue 2, pp. 202 - 216
T cell-mediated immunotherapies are promising cancer treatments. However, most patients still fail to respond to these therapies. The molecular determinants of... 
BRAF INHIBITION | METASTATIC MELANOMA | PI3K | ONCOLOGY | PD-L1 EXPRESSION | TUMOR-SUPPRESSOR | RECEPTOR | AUTOPHAGY | CONTRIBUTES | ADOPTIVE IMMUNOTHERAPY | INFILTRATION | Aminopyridines - administration & dosage | Antibodies - therapeutic use | Immunotherapy - methods | PTEN Phosphohydrolase - deficiency | Humans | Morpholines - administration & dosage | Drug Resistance, Neoplasm | CTLA-4 Antigen - immunology | Drug Synergism | Antibodies - administration & dosage | Animals | Aminopyridines - therapeutic use | Melanoma - genetics | Melanoma - immunology | Melanoma - drug therapy | Cell Line, Tumor | T-Lymphocytes - immunology | Mice | Programmed Cell Death 1 Receptor - immunology | Morpholines - therapeutic use | PTEN loss | Immunotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cortical Morphologic Features of Axillary Lymph Nodes as a Predictor of Metastasis in Breast Cancer: In Vitro Sonographic Study
by Bedi, Deepak G and Krishnamurthy, Rajesh and Krishnamurthy, Savitri and Edeiken, Beth S and Le-Petross, Huong and Fornage, Bruno D and Bassett, Roland L., Jr and Hunt, Kelly K
American Journal of Roentgenology, ISSN 0361-803X, 09/2008, Volume 191, Issue 3, pp. 646 - 652
OBJECTIVE. The purpose of this study was in vitro sonographic-pathologic correlation of findings in dissected axillary lymph nodes from breast cancer patients... 
Nodal metastasis | Nodal sonography | Breast cancer | MAMMOGRAPHY | ULTRASOUND | BENIGN | breast cancer | nodal metastasis | ULTRASONOGRAPHY | nodal sonography | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Axilla - diagnostic imaging | Reproducibility of Results | Prognosis | Ultrasonography, Mammary - methods | Humans | Middle Aged | Sensitivity and Specificity | Adult | Female | Lymphatic Metastasis | Breast Neoplasms - diagnostic imaging | Lymph Nodes - diagnostic imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer
by Takeuchi, Satoshi and Khiewvan, Benjapa and Fox, Patricia S and Swisher, Stephen G and Rohren, Eric M and Bassett Jr, Roland L and Macapinlac, Homer A
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 5/2014, Volume 41, Issue 5, pp. 906 - 914
Our objective was to determine the impact of initial 18F-FDG PET/CT (PET/CT) staging on clinical stage and the management plan and the prognostic value of... 
Impact | Prognostic value | Clinical stage | Medicine & Public Health | Initial 18 F-FDG PET/CT | Management plan | Orthopedics | Non-small-cell lung cancer | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | FORTHCOMING 7TH EDITION | REVISION | PROJECT | INTEGRATED FDG-PET/CT | TNM CLASSIFICATION | F-18-FDG PET | PROPOSALS | POSITRON-EMISSION-TOMOGRAPHY | Initial F-18-FDG PET/CT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | REGISTRY | Predictive Value of Tests | Prognosis | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Multimodal Imaging | Female | Lung Neoplasms - diagnostic imaging | Aged | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Neoplasm Staging | PET imaging | Lung cancer, Non-small cell | Mortality | Clinical trials | Medical imaging | Medical diagnosis | Lung cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text 18F-FDG PET/CT as an indicator of progression-free and overall survival in osterosarcoma
by Costelloe, Colleen M and Macapinlac, Homer A and Madewell, John E and Fitzgerald, Nancy E and Mawlawi, Osama R and Rohren, Eric M and Raymond, A. Kevin and Lewis, Valerae O and Anderson, Peter M and Bassett Jr, Roland L and Harrell, Robyn K and Marom, Edith M
Journal of Nuclear Medicine, ISSN 0161-5505, 03/2009, Volume 50, Issue 3, pp. 340 - 347
Molecular imaging | Osteosarcoma | PET/CT | F-FDG | Survival | Tumor necrosis | PET
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction
by Carter, Stacey A and Lyons, Genevieve R and Kuerer, Henry M and Bassett Jr, Roland L and Oates, Scott and Thompson, Alastair and Caudle, Abigail S and Mittendorf, Elizabeth A and Bedrosian, Isabelle and Lucci, Anthony and DeSnyder, Sarah M and Babiera, Gildy and Yi, Min and Baumann, Donald P and Clemens, Mark W and Garvey, Patrick B and Hunt, Kelly K and Hwang, Rosa F
Annals of Surgical Oncology, ISSN 1068-9265, 10/2016, Volume 23, Issue 10, pp. 3190 - 3198
Oncoplastic reconstruction is an approach that enables patients with locally advanced or adversely located tumors to undergo breast conserving surgery (BCS).... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | WOMEN | ONCOLOGY | CONSERVING SURGERY | SURGICAL TECHNIQUES | PARTIAL MASTECTOMY | PATTERNS | COMPLICATIONS | MARGINS | TUMOR-BED | QUADRANT | RADIATION-THERAPY | Breast Neoplasms - surgery | Follow-Up Studies | Mastectomy, Simple - adverse effects | Humans | Middle Aged | Margins of Excision | Survival Rate | Treatment Outcome | Mastectomy, Segmental - adverse effects | Neoplasm, Residual | Young Adult | Disease-Free Survival | Mammaplasty - adverse effects | Seroma - etiology | Breast Neoplasms - pathology | Mammaplasty - trends | Aged, 80 and over | Mastectomy, Segmental - trends | Adult | Female | Aged | Retrospective Studies | Neoplasm Staging | Lumpectomy | Cancer patients | Breast cancer | Patient outcomes | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages
by Silva-Figueroa, Angelica and Villalobos, Pamela and Williams, Michelle D and Bassett, Roland L and Clarke, Callisia N and Lee, Jeffrey E and Busaidy, Naifa L and Perrier, Nancy D
Surgery (United States), ISSN 0039-6060, 11/2018, Volume 164, Issue 5, pp. 960 - 964
Background: Four distinct tumor microenvironments have been proposed based on the expression of programmed death-ligand 1 and the presence of... 
SURGERY | PD-L1 | THERAPY | CANCER-IMMUNOTHERAPY | COMBINATION | Immune response | Macrophages | Lymphocytes | Immunotherapy | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience
by Nelson, David B and Mehran, Reza J and Mitchell, Kyle G and Rajaram, Ravi and Correa, Arlene M and Bassett, Roland L and Antonoff, Mara B and Hofstetter, Wayne L and Roth, Jack A and Sepesi, Boris and Swisher, Stephen G and Walsh, Garrett L and Vaporciyan, Ara A and Rice, David C
The Annals of Thoracic Surgery, ISSN 0003-4975, 08/2019, Volume 108, Issue 2, pp. 370 - 376
It is unclear whether the enhanced dexterity and visualization of the surgical robot lessens morbidity and influences staging or survival. We compared outcomes... 
SURGERY | LYMPH-NODE EVALUATION | CARDIAC & CARDIOVASCULAR SYSTEMS | RESECTION | RESPIRATORY SYSTEM | CLINICAL STAGE-I | THORACOTOMY | PROPENSITY-MATCHED ANALYSIS | THORACIC-SURGERY LOBECTOMY | THORACOSCOPIC SURGERY | SOCIETY | Robotic surgery | Analysis | Mortality | Lung cancer, Small cell | Lung cancer, Non-small cell | Health aspects | Robots
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Multi-institutional comparison of Whole slide digital imaging and optical microscopy for interpretation of hematoxylin-eosin-stained breast tissue sections
by Krishnamurthy, Savitri and Mathews, Kurt and McClure, Steven and Murray, Melissa and Gilcrease, Michael and Albarracin, Constance and Spinosa, John and Chang, Bernard and Ho, James and Holt, John and Cohen, Arthur and Giri, Dilip and Garg, Karuna and Bassett Jr, Roland L and Liang, Kevin
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 12/2013, Volume 137, Issue 12, pp. 1733 - 1739
Context.-Whole slide imaging (WSI) is now used for educational purposes, for consultation, and for archiving and quantitation of immunostains. However, it is... 
MEDICINE, RESEARCH & EXPERIMENTAL | TELEPATHOLOGY | DIAGNOSIS | DESIGN | NETWORK | VIRTUAL MICROSCOPY | IMPLEMENTATION | VALIDATION | PATHOLOGY | MEDICAL LABORATORY TECHNOLOGY | INTEROBSERVER | PROSTATE NEEDLE BIOPSIES | Microscopy - methods | Carcinoma, Lobular - pathology | Diagnosis, Differential | Reproducibility of Results | Histocytochemistry - methods | Humans | Image Interpretation, Computer-Assisted - methods | Optical Imaging - standards | Carcinoma, Lobular - diagnosis | Diagnostic Imaging - standards | Carcinoma, Ductal, Breast - diagnosis | Diagnostic Imaging - methods | Breast Neoplasms - pathology | Hematoxylin | Carcinoma, Ductal, Breast - pathology | Female | Breast Neoplasms - diagnosis | Image Interpretation, Computer-Assisted - standards | Microscopy - standards | Optical Imaging - methods | Eosine Yellowish-(YS) | Medicine, Experimental | Medical research | Comparative analysis | Microscope and microscopy | Medical societies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Ipilimumab plus lenalidomide after allogeneic and autologous stem cell transplantation for patients with lymphoid malignancies
by Khouri, Issa F and Curbelo, Irina Fernandez and Turturro, Francesco and Jabbour, Elias J and Milton, Denai R and Bassett, Roland L and Vence, Luis M and Allison, James P and Gulbis, Alison M and Sharma, Padmanee
Clinical Cancer Research, ISSN 1078-0432, 03/2018, Volume 24, Issue 5, pp. 1011 - 1018
Purpose: Prevention or treatment of relapsed lymphoid malignancies after hematopoietic stem cell transplantation (HSCT) requires novel strategies. We... 
MULTIPLE-MYELOMA | SURVIVAL | METASTATIC MELANOMA | CTLA-4 BLOCKADE | RELAPSE | ONCOLOGY | RITUXIMAB | ANTIBODY | FOLLICULAR LYMPHOMA | THALIDOMIDE ANALOG | ANTITUMOR IMMUNITY | Graft vs Host Disease - epidemiology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Graft vs Host Disease - immunology | CD4-Positive T-Lymphocytes - immunology | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Lymphoma - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Lymphoma - pathology | Ipilimumab - administration & dosage | Transplantation, Homologous - adverse effects | Drug Administration Schedule | Neoplasm Recurrence, Local - therapy | Lymphoma - immunology | Treatment Outcome | Ipilimumab - adverse effects | Transplantation, Autologous - methods | Lenalidomide - administration & dosage | Pilot Projects | Graft vs Host Disease - chemically induced | Lenalidomide - adverse effects | Transplantation, Autologous - adverse effects | Aged | Hematopoietic Stem Cell Transplantation - methods | CD4-Positive T-Lymphocytes - drug effects | Transplantation, Homologous - methods | Graft-versus-host reaction | Intravenous administration | Transplants & implants | Toxicity | Stem cell transplantation | Cytotoxicity | Transplantation | Lymphocytes T | Dermatitis | Hematopoietic stem cells | Safety engineering | Foxp3 protein | Remission | Autografts | Immune response | Risk groups | Hypothyroidism | Patients | CD4 antigen | Hemopoiesis | Experimental design | Cell number | ICOS protein | Stem cells | Antitumor activity | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma
by Schvartsman, Gustavo and Ma, Junsheng and Bassett, Jr, Roland L and Haydu, Lauren E and Amaria, Rodabe Navroze and Hwu, Patrick and Wong, Michael K and Hwu, Wen-Jen and Diab, Adi and Patel, Sapna Pradyuman and Davies, Michael A and Hamerschlak, Nelson and Tawbi, Hussein Abdul-Hassan and Glitza Oliva, Isabella C
Cancer, ISSN 0008-543X, 08/2019
Melanoma brain metastases (MBM) occur in up to 50% of patients with metastatic melanoma (MM) and represent a frequent site of systemic treatment failure for... 
Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value
by Hidalgo‐Lόpez, Juliana E and Kanagal‐Shamanna, Rashmi and Quesada, Andrés E and Gong, Zimu and Wang, Wei and Hu, Shimin and Medeiros, L. Jeffrey and Bassett, Roland L and d’Orcy, Elizabeth and Yin, C. Cameron and Cortes, Jorge and Jabbour, Elias J and Kantarjian, Hagop M and Bueso‐Ramos, Carlos E
Cancer, ISSN 0008-543X, 10/2018, Volume 124, Issue 19, pp. 3849 - 3855
Bone marrow biopsy is valuable in the workup of approximately 25% of patients with chronic myeloid leukemia because it facilitates identification of the... 
chronic myeloid leukemia | BCR‐ABL | bone marrow biopsy | accelerated phase | blast phase | BCR-ABL | 5-YEAR | CML | MANAGEMENT | ABNORMALITIES | TRANSCRIPTS | CHROMOSOME | POLYMERASE-CHAIN-REACTION | ONCOLOGY | ERA | RECOMMENDATIONS | IMATINIB | Myelofibrosis | Biopsy | Myeloid leukemia | Leukemia | Bone marrow | Chronic myeloid leukemia | Added value | Diagnosis | Blast | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma
by Romero Arenas, Minerva A and Rich, Thereasa A and Hyde, Samuel M and Busaidy, Naifa L and Cote, Gilbert J and Hu, Mimi I and Gagel, Robert F and Gidley, Paul W and Jimenez, Camilo and Kupferman, Michael E and Peterson, Susan K and Sherman, Steven I and Ying, Anita and Bassett Jr, Roland L and Waguespack, Steven G and Perrier, Nancy D and Grubbs, Elizabeth G
Annals of Surgical Oncology, ISSN 1068-9265, 5/2018, Volume 25, Issue 5, pp. 1395 - 1402
No guidelines exist regarding physicians’ duty to inform former patients about novel genetic tests that may be medically beneficial. Research on the... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | GENERAL-POPULATION | BREAST-OVARIAN CANCER | DECISION-MAKING | ONCOLOGY | NONPOLYPOSIS COLORECTAL-CANCER | FAMILY-MEMBERS | SUSCEPTIBILITY | CLINICAL-PRACTICE GUIDELINE | RISK | HEREDITARY COLON-CANCER | ATTITUDES | Genetic Counseling - psychology | Genetic Testing | Paraganglioma - genetics | Humans | Middle Aged | Carcinoma, Neuroendocrine - genetics | Male | Health Knowledge, Attitudes, Practice | Thyroid Neoplasms - genetics | Motivation | Aged, 80 and over | Adult | Female | Pheochromocytoma - genetics | Surveys and Questionnaires | Aged | Adrenal Gland Neoplasms - genetics | Communication | Physician's Role | Patient education | Thyroid cancer | Pheochromocytoma | Physicians | Genetic screening | Medical genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow‐up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients
by Qiu, Wei and Christakis, Ioannis and Silva, Angelica and Bassett, Roland L and Cao, Liyun and Meng, Qing H and Gardner Grubbs, Elizabeth and Zhao, Hua and Yao, James C and Lee, Jeffrey E and Perrier, Nancy D
Clinical Endocrinology, ISSN 0300-0664, 09/2016, Volume 85, Issue 3, pp. 400 - 407
ObjectivePancreatic neuroendocrine tumours (PNETs) are the major source of disease-specific mortality in multiple endocrine neoplasia type 1 (MEN1) patients.... 
LONG-TERM | SURVIVAL | CONSENSUS GUIDELINES | BIOMARKER | MARKER | ENDOCRINOLOGY & METABOLISM | MEN1 | Gastrins - blood | Area Under Curve | Pancreatic Neoplasms - diagnosis | Humans | Middle Aged | Male | Neuroendocrine Tumors - diagnosis | Glucagon - blood | Biomarkers, Tumor - blood | Young Adult | Pancreatic Polypeptide - blood | Adolescent | Multiple Endocrine Neoplasia Type 1 - pathology | Adult | Female | Aged | Retrospective Studies | Chromogranin A - blood | Diagnosis | Glucagon | Mortality | Gastrin | Tumors | Pancreatic neuroendocrine tumors | Chromogranin A | Pancreatic polypeptide
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Assessment of BRAF V600E status in colorectal carcinoma: Tissue-specific discordances between immunohistochemistry and sequencing
by Estrella, Jeannelyn S and Tetzlaff, Michael T and Bassett, Roland L and Patel, Keyur P and Williams, Michelle D and Curry, Jonathan L and Rashid, Asif and Hamilton, Stanley R and Broaddus, Russell R
Molecular Cancer Therapeutics, ISSN 1535-7163, 12/2015, Volume 14, Issue 12, pp. 2887 - 2895
Although sequencing provides the gold standard for identifying colorectal carcinoma with BRAF V600E mutation, immunohistochemistry (IHC) with the recently... 
COLON-CANCER | CANCER GENOME ATLAS | BRAF(V600E) MUTATION | ONCOLOGY | POOR SURVIVAL | VE1 ANTIBODY | PAPILLARY THYROID-CARCINOMA | MONOCLONAL-ANTIBODY | LYNCH SYNDROME | MALIGNANT-MELANOMA | EXPRESSION | Proto-Oncogene Proteins B-raf - isolation & purification | Colorectal Neoplasms - genetics | Humans | Organ Specificity | Immunohistochemistry - standards | Thyroid Cancer, Papillary | Antibodies, Monoclonal - genetics | Thyroid Neoplasms - genetics | Animals | Carcinoma, Papillary | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Carcinoma - genetics | Mice | Mutation | Colorectal Neoplasms - pathology | High-Throughput Nucleotide Sequencing - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights